Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats  by Ayepola, Omolola R. et al.
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Diabetic  nephropathy  is  a complex  disease  that involves  increased  production  of  free  radicals  which  is a
strong  stimulus  for  the  release  of pro-inﬂammatory  factors.  We  evaluated  the renal  protective  effect  of
kolaviron (KV)  – a Garcinia  kola seed  extract  containing  a  mixture  of 5 ﬂavonoids,  in diabetes-induced
nephrotoxic rats. Male  Wistar  rats  were  divided  into  4  groups:  untreated  controls  (C);  normal  rats  treated
with kolaviron  (C + KV);  untreated  diabetic  rats  (D);  kolaviron  treated  diabetic  rats  (D +  KV). A single
intraperitoneal  injection  of  streptozotocin  (STZ,  50 mg/kg)  was  used  for  the induction  of diabetes.  Renal
function  parameters  were  estimated  in  a clinical  chemistry  analyzer.  Markers  of oxidative  stress  in the
kidney  homogenate  were  analyzed  in  a Multiskan  Spectrum  plate  reader  and  Bio-plex  Promagnetic  bead-
based assays  was  used  for  the analysis  of  inﬂammatory  markers.  The  effect  of  kolaviron  on  diabetes-
induced  apoptosis  was  assessed  by  TUNEL  assay.  In the  diabetic  rats,  alterations  in antioxidant  defenses
such  as an  increase  in  lipid  peroxidation,  glutathione  peroxidase  (GPX)  activity  and  a decrease  in  catalase
(CAT)  activity,  glutathione  (GSH)  levels  and  oxygen  radical  absorbance  capacity  (ORAC)  were  observed.
There  was  no  difference  in superoxide  dismutase  (SOD)  activity.  Diabetes  induction  increased  apoptotic
cell  death  and  the  levels  of interleukin  (IL)-1  and  tumor  necrosis  factor  (TNF)-  with  no  effect  on
IL-10.  Kolaviron  treatment  of  diabetic  rats  restored  the  activities  of antioxidant  enzymes,  reduced  lipid
peroxidation  and  increased  ORAC  and  GSH  concentration  in  renal  tissues.  Kolaviron  treatment  of  diabetic
rats also  suppressed  renal  IL-1.  The beneﬁcial  effects  of  kolaviron  on diabetes-induced  kidney  injury
may  be due  to  its inhibitory  action  on oxidative  stress,  IL-1  production  and  apoptosis.
©  2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CCntroduction
Diabetes mellitus has dramatically increased globally. Diabetes
an result in a progressive decline in glomerular ﬁltration rate
haracterized by glomerular hyperﬁltration, glomerular and tubu-
ar epithelial hypertrophy, increased urinary albumin excretion,
ncreased basement membrane thickness and mesangial expansion
ith the accumulation of extracellular matrix (ECM) proteins (Jain
012). The progression of renal injury often leads to end-stage renal
isease affecting 20–40% of diabetic patients (Hakim and Pﬂueger
010). Oxidative stress induced by the hyperglycemic milieu drives
∗ Corresponding author. Tel.: +27 21 953 8495; fax: +27 21953 8490.
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icenses/by-nc-nd/3.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
the development of complications including diabetic nephropathy
(Kawahito et al. 2009). The initial cellular response to high glu-
cose challenge also rapidly induces apoptosis (Park et al. 2001).
Furthermore, the recruitment of inﬂammatory cells from the cir-
culation into renal tissue is a critical feature of diabetic nephropathy
(Navarro-González et al. 2011). Streptozotocin is selectively toxic
to insulin-secreting beta cells of pancreatic islets inducing beta cell
necrosis and impairs glucose oxidation and insulin release (Hayden
and Tyagi 2002; Merzouk et al. 2000) and, in rats, mimics human
diabetes (Weir et al. 1981) therefore it is a good experimental model
for diabetic renal injury.
Garcinia kola seeds (Family: Guttiferae) are consumed in west
and central Africa and contain high biﬂavonoid levels which
have several pharmacokinetic advantages over simple monomeric
ﬂavonoids as they survive ﬁrst-pass metabolism (Iwu and Igboko
1986). Kolaviron (KV) is a mixture of ﬂavonoids extracted from
access article under the CC BY-NC-ND license (http://creativecommons.org/
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he seeds of Garcinia kola which has numerous therapeutic effects.
lthough, kolaviron has been reported to produce a hypoglycemic
nd hypocholesterolemic effects in diabetic animals (Iwu et al.
990; Adaramoye and Adeyemi 2006) and to protect against
xidative stress induced by toxins in experimental animal mod-
ls (Akintonwa and Essien 1990; Farombi 2000), its efﬁcacy in
odulating the complex responses associated with oxidative stress
nd inﬂammation in diabetic kidney damage remains to be elu-
idated. In this study, we hypothesized that supplementation of
olaviron protects against diabetic kidney damage resulting from
yperglycemia-induced oxidative stress, inﬂammation and apo-
tosis in rats.
aterials and methods
nimals
The study protocol was  approved by the Faculty of Health and
ellness Sciences Research Ethics Committee of the Cape Penin-
ula University of Technology (Ethics Certiﬁcate no: CPUT/HW-REC
012/AO4). All the animals received humane care in accordance
ith the criteria outlined in the ‘Guide for the Care and Use of
aboratory Animals’ prepared by the National Academy of Science
NAS) and published by the National Institute of Health (Publi-
ation no. 80-23, revised 1978). Male Wistar rats (11–12 weeks,
70 ± 25 g) were used for the study. Experiments were performed
t the animal facility of the Medical Research Council (MRC) and
trictly adhered to the standard operating procedures (SOPs). All
nimals were housed individually at room temperature (22 ± 2 ◦C)
ith 55 ± 5% humidity and an automatically controlled cycle of
2 h light and 12 h dark. A standard laboratory diet and water were
rovided ad libitum and rats were habituated to the experimental
onditions one week prior to experimentation.
nduction of diabetes
To induce diabetes in rats, a single intraperitoneal injection of
reshly prepared solution of 50 mg/kg of STZ (Sigma–Aldrich, SA) in
itrate buffer (0.1 M,  pH 4.5) was administered to overnight fasted
ats. Diabetes was conﬁrmed after a tail prick by stable hyper-
lycemia (>18 mmol/l) ﬁve days post-STZ injection using a portable
lucometer (Accu-Chek, Roche, Germany).
lant materials
Fresh seeds of Garcinia kola were purchased from Bodija mar-
et in Ibadan, Oyo State, Nigeria and authenticated by Professor
. A Ayodele at the Department of Botany, University of Ibadan. A
oucher specimen (FHI-109777) is available at the herbarium of the
orestry Research Institute of Nigeria (FRIN), Ibadan.
xtraction of kolaviron
Garcinia kola seeds were peeled, sliced and air-dried (25–28 ◦C).
olaviron was isolated according to the method of Iwu  et al. (1990).
he powdered seeds (600 g) were defatted with 800 ml  of light
etroleum ether (bp 40–60 ◦C) in a soxhlet for 24 h. The defat-
ed powder was spread in thin layers on trays and air dried at
oom temperature for 24 h, repacked in the soxhlet and extracted
ith acetone (500 ml)  at a temperature of 40 ◦C. The extract was
oncentrated and diluted twice its volume with distilled water
nd extracted with ethylacetate (6 ml  × 300 ml). The concentrated
thylacetate yielded kolaviron.ine 21 (2014) 1785–1793
Liquid chromatography–mass spectrometry (LC–MS) analysis of
Garcinia kola seed extract
LC–MS was  performed on a Dionex HPLC system (Dionex Soft-
ron, Germering, Germany) equipped with a binary solvent manager
and autosampler coupled to a Brucker ESI Q-TOF mass spectrom-
eter (Bruker Daltonik GmbH, Germany) as previously described
(Ayepola et al. 2013). Kolaviron was  separated by reversed phase
chromatography on a Thermo Fischer Scientiﬁc C18 column 5 m;
4.6 mm × 150 mm (Bellefonte, USA) using gradient elution with
0.1% formic acid in water (solvent A) and acetonitrile (solvent B)
as solvent at a ﬂow rate of 1.0 ml  min−1, an injection volume of
10 l and an oven temperature of 30 ◦C. MS  spectra were acquired
in negative mode using the full scan and auto MS/MS (collision
energy 25 eV) scan modes with dual spray for reference mass solu-
tion. Electrospray voltage was set to +3500 V. Dry gas ﬂow was set
to 9 l min−1 with a temperature of 300 ◦C and nebulizer gas pressure
was set to 35 psi.
Study design
The rats were randomly assigned into four groups (n = 10 per
group): control (C), KV-treated control (C + KV), diabetic (D) and KV-
treated diabetic (D + KV). Treatment commenced on the sixth day
post STZ injection and continued for 6 weeks. The 100 mg/kg dose
of kolaviron was  selected based on our preliminary investigation.
This 100 mg/kg kolaviron dose was  a more effective dose among the
doses (100 and 200 mg/kg) investigated in our preliminary study.
Kolaviron (100 mg/kg body weight), dissolved in dimethylsulphox-
ide (DMSO) was  administered by gastric gavage ﬁve times weekly.
The dosage of kolaviron was adjusted weekly according to changes
in body weight to standardize the dosages over the duration of the
study.
Blood and tissue collection
After treatment, the rats were weighed and anesthetized with
an intraperitoneal injection of sodium pentobarbital (60 mg/kg).
Blood was  collected in tubes without anticoagulant for serum sep-
aration. Blood samples were centrifuged at 4000 × g for 10 min  at
4 ◦C. Aliquots of the supernatant were stored at −80 ◦C for biochem-
ical analysis. The left kidney was rapidly excised, washed in ice-cold
phosphate buffered saline, blotted, frozen in liquid nitrogen and
stored at −80 ◦C until use whereas the right kidney was  excised
and ﬁxed in 10% (v:v) neutral buffered formalin.
Determination of relative kidney weight
Hypertrophy of the kidney was estimated by comparing the
kidney weight to the body weight (relative kidney weight).
Relative kidney weight(mg/100 g body weight)
= Kidney weight(g)
Total body weight(g)
× 100
Analysis of renal function parameters
Serum uric acid, blood urea nitrogen (BUN) and albumin concen-
trations were analyzed with diagnostic kits in an automated clinical
chemistry analyzer (Medical Cooperation, Bedford, MA,  USA).Oxygen radical absorbance capacity (ORAC)
The ORAC assay kinetically measured the peroxyl radical
scavenging activity in kidneys with trolox as the antioxidant
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Treatment of diabetic rats with kolaviron reduced the relative kid-O.R. Ayepola et al. / Phyto
tandard according to the method of Ou and Hampsch-Woodill
rior (2001). The ﬂuorescence of the reaction mixture was
onitored and recorded every minute (excitation = 485 nm and
mission = 535 nm)  for 2 h with a Fluoroscan Ascent plate
eader (Thermo Fischer Scientiﬁc, Waltham, MA,  USA). Results
ere determined with a regression equation relating trolox
oncentrations and the net area under the kinetic ﬂuo-
escein decay curve (y = ax2  + bx + c). The ORAC value was
xpressed in micromoles of trolox equivalents per gram of tissue
mol  TE/g).
easurement of antioxidant enzyme activities
Activities of antioxidant enzymes were determined in a clear
6-well plate using a Multiskan Spectrum plate reader (Thermo
isher Scientiﬁc, USA). Catalase (CAT) activity was determined by
he method of Aebi (1984). Superoxide dismutase (SOD) was deter-
ined by the method of Crosti et al. (1987). Glutathione Peroxidase
GPX) activity was determined according to the method of Ellerby
nd Bredesen (2000). The protein level in the kidney was  estimated
ith a bicinchoninic acid (BCA) kit (Pierce, IL, USA).
etermination of glutathione (GSH) concentrations
The concentration of reduced glutathione (GSH) in the kidney
as estimated by the method of Jollow et al. (1974).
easurement of lipid peroxidation
Kidney malondialdehyde (MDA) was determined by high per-
ormance liquid chromatography (HPLC) using a method adapted
rom Khoschsorur et al. (2000). Fluorometric detection was per-
ormed with excitation at 532 nm and emission at 552 nm. The peak
f the MDA-TBA adduct was calibrated with the MDA  standard.
etermination of renal interleukin (IL)-1ˇ, IL-10 and TNF-˛
oncentrations
The levels of IL-1, IL-10 and TNF- were determined in the rat
idney homogenate using Bio-plex Promagnetic bead-based assay
Bio-Rad Laboratories, Hercules, USA) on the Bio-plex platform
Bio-Rad). Following previous optimization, undiluted samples
ere blindly evaluated. Samples were reacted with a mixture of
uorescent polystyrene beads bound with speciﬁc anti-cytokine
rimary antibodies, resulting in binding of the cytokines to the
eads with the corresponding antibody. The biotinylated anti-
ytokine secondary antibodies were then added and allowed to
ind to the cytokine-bead complex followed by the addition of
uorescent phycoerythrin-conjugated streptavidin. Bio-Plex Man-
ger software version 6.0 was used for bead acquisition and
nalysis.
ssessment of apoptosis
The right kidney was excised, ﬁxed in 10% (v:v) neutral buffered
ormalin and dehydrated in ascending grades of ethanol, cleaned
n xylene and embedded in parafﬁn. Apoptosis was determined
y terminal deoxynucleotidyl transferase-mediated dUTP-biotin
ick end labeling (TUNEL) using ApopTag ﬂuorescein in situ Apo-
tosis Detection Kit (#S7110; Millipore, Temecula, CA) according
o the manufacturer’s instruction without modiﬁcation. Parafﬁn-
mbedded kidney sections (5 m)  were layered onto glass slides,
ewaxed in xylene and rehydrated in graded dilutions of ethanol.
ections were treated with freshly diluted protein digesting
nzyme, proteinase K (20 g/ml) for 15 min  at room temperature.
quilibration buffer was applied directly on the kidney sectionsne 21 (2014) 1785–1793 1787
followed by incubation with the TUNEL reaction mixture con-
taining terminal deoxynucleotidyl transferase (TdT), digoxigenin
nucleotide and unlabeled nucleotide for 1 h in a humidiﬁed cham-
ber at 37 ◦C. Antidigoxigenin conjugate was  applied directly to the
slides and sections were counter stained with propidium iodide
(PI), mounted and viewed on a Carl Zeiss LSM 780 confocal micro-
scope using a Plan-Neoﬂuar 40X objective. Samples were excited
with an argon mutline laser with excitation at 488 nm (for green)
and 561 nm (for red). Images were acquired with a GaAsP detector
set up for standard FITC and PI detection and optimized with the
Carl Zeiss ZEN 2011 (Germany) software package. Total cell pop-
ulation and apoptotic cells were counted using the Image J image
analysis software. TUNEL positive cells were expressed as percent-
age of total cells.
Histology
Kidney tissue was ﬁxed in 10% (v:v) neutral buffered formalin
and embedded in parafﬁn wax. Fixed kidney tissues were cut into
5 m slices. After being deparafﬁnized using xylene and ethanol
dilutions and rehydration, tissue sections were stained with hema-
toxylin and eosin (H&E). Mounted slides were examined in a
masked fashion under a light microscope and photographed using
a digital camera.
Statistical analysis
Data were expressed as the means ± standard deviations. Sig-
niﬁcant differences between mean values of different groups
were determined by one-way analysis of variance (ANOVA) with
MedCalc software. Data not normally distributed was  log trans-
formed and analyzed using the Kruskal–Wallis one-way ANOVA
on ranks hypotheses. Differences were considered signiﬁcant at
p < 0.05.
Results
LC–MS analysis of Garcinia kola seed extract
LC–MS analysis of Garcinia kola seed extract shows molec-
ular ion peaks [M−H]− at (1) m/z 573.1023, (2) m/z  557.1074,
(4) m/z 557.1072 (3) m/z 587.1178, (5) m/z 541.1123 and (6)
m/z 555.0909 (Fig. 1). The molecular mass corresponds respec-
tively to the active constituents (Fig. 2); Garcinia biﬂavonoid 2
(m/z 573.1023 = C30H22O12), Garcinia biﬂavonoid 1 (m/z 557.1074,
557.1072 = C30H22O11), kolaﬂavanone (m/z 587.1178 = C31H24O12)
and kolaﬂavones (m/z 555.0909 = C30H21O11) which have been pre-
viously identiﬁed in kolaviron (Iwu et al. 1990). The mass spectrum
of peak 5 shows the ion peak [M−H]− at m/z 541.1123. On the basis
of this data and database searching, we deduce that this compound
(peak 5) is binaringenin, a biﬂavanone which has been reported in
Garcinia species (Waterman 1983).
Kolaviron’s effect on weight parameters and renal function in
normal and STZ-induced diabetic rats
There was  an increase in the relative kidney weight of the dia-
betic rats compared to control rats (Table 1). Elevated serum levels
of blood urea nitrogen and uric acid and a decrease in albumin lev-
els were also observed in the diabetic rats compared to control rats.ney weight and the serum levels of kidney function biomarkers, viz.,
uric acid, blood urea nitrogen and increased albumin concentra-
tion. Administration of kolaviron to non-diabetic control rats had
no adverse effect on the kidney.
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Fig. 1. LC–MS analysis of Garcinia kola seed extracts (kolaviron). (1) Garcinia biﬂavonoid 2 (C30H22O12, m/z 573.1023); (2) Garcinia biﬂavonoid 1 (C30H22O11, m/z 557.1074);
(3)  kolaﬂavanone (C31H24O12, m/z 587.1178); (4) Garcinia biﬂavonoid 1 (C30H22O11, m/z 557.1072); (5) X (C30H22O10, 541.1123), deduced to be binaringenin; (6) Kolaﬂavone
(C30H21O11, m/z 555.0909). According to the LC–MS analysis, the approximate ratios of the single compounds in kolaviron are; 0.18: 0.38: 0.14: 0.11: 0.12: 0.06 respectively.
Table 1
Effect of kolaviron on weight parameters and serum markers of kidney damage.
C C + KV D D + KV
Change in body weight (%) +33.34 +33.84 −3.52a +17.30b
Kidney weight (g) 1.34 ± 0.09 1.37 ± 0.07 1.28 ± 0.09 1.38 ± 0.09
Relative  kidney weight (g/100 g) 0.33 ± 0.02 0.35 ± 0.04 0.5 ± 0.03a 0.43 ± 0.04b
Uric acid (unit) 48.83 ± 9.87 49.27 ± 7.06 82.8 + 11.35a 55.29 ± 12.34b
BUN (unit) 6.46 ± 0.77 6.17 ± 0.5 18.35 ± 2.90a 8.28 ± 1.21b
Albumin (unit) 30.84 ± 0.91 30.18 ± 0.62 26.23 ± 0.72a 27.4 ± 0.98b
Data are presented as means ± S.D. C, non-diabetic control rats; C + KV, kolaviron-treated control rats; D, untreated diabetic rats; D + KV, KV-treated diabetic rats; BUN, blood
urea  nitrogen.
a Values differ from control rats (p < 0.05).
b Values differ from diabetic rats (p < 0.05).
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ffect of kolaviron on kidney antioxidant enzymes (CAT, SOD, GPX)
nd non-enzyme (GSH) in normal and STZ-induced diabetic rats
Table 2 illustrates the effect of kolaviron on glutathione con-
entration and activities of catalase (CAT), superoxide dismutase
SOD) and glutathione peroxidase (GPX) in the control and diabetic
at kidney. The induction of diabetes with STZ reduced kidney glu-
athione (GSH) concentration and CAT activity in the diabetic rats.
PX activity was elevated in diabetic rats compared to control rats
ith no differences in SOD activities among the groups. Kolaviron
reated diabetic rats demonstrated increased GSH concentration
nd CAT activity compared to diabetic controls. GPX activity was
lso normalized after kolaviron administration to diabetic rats.
olaviron also increased GSH concentration in renal tissues of non-
iabetic rats.
xygen radical absorbance capacity of kolaviron and its effect on
ipid peroxidation in the kidney of normal and STZ-induced
iabetic rats
As shown in Table 3, malondialdehyde (MDA; lipid peroxidation
arker) levels were elevated in the kidneys of diabetic control rats
hereas oxygen radical absorbance capacity (ORAC) values were
educed compared to non-diabetic control. Kolaviron treatment
educed MDA  levels and increased ORAC values in diabetic rats
able 2
ffect of kolaviron on renal antioxidant status.
C C + KV D D + KV
CAT 1.32 ± 0.26 1.31 ± 0.24 0.95 ± 0.24a 1.16 ± 0.19
SOD 401.70 ± 40.32 386.85 ± 43.53 423.68 ± 28.56 391.87 ± 39.17
GPX 4.76 ± 0.37 3.93 ± 0.61 6.09 ± 0.89a 4.70 ± 0.90b
GSH 1.19 ± 0.07 1.33 ± 0.10a 0.96 ± 0.14a 1.10 ± 0.13b
ata are presented as mean ± S.D. C, non-diabetic control rats; C + KV, kolaviron-
reated control rats; D, untreated diabetic rats; D + KV, kolaviron-treated diabetic
ats; CAT, catalase; mol H2O2 consumed/min/mg protein; SOD, superoxide dis-
utase; U/mg protein, GPX, glutathione peroxidase; mol  NADPH oxidized/min/ g
rotein; GSH, reduced glutathione; mol/g tissue.
a Values differ signiﬁcantly from control (p < 0.05).
b Values differ signiﬁcantly from diabetic control (p < 0.05).avonoids from Garcinia kola seeds.
compared to diabetic control rats. Kolaviron-treated control rats
also had increased ORAC values compared to untreated control rats.
Effect of kolaviron on pro-inﬂammatory cytokines [interleukin
(IL)-1ˇ, tumor necrosis factor (TNF-˛)] and anti-inﬂammatory
cytokine (IL-10) in normal and STZ-induced diabetic rats
The induction of diabetes increased renal TNF- and IL-1 con-
centrations (Fig. 3). The increase in IL-1 was inhibited after the
administration of kolaviron although no statistically signiﬁcant
effect was  observed in the renal concentration of TNF- in the dia-
betic rats after kolaviron treatment. No signiﬁcant difference was
observed in the levels of IL-10 among the groups.
Effect of kolaviron on apoptosis in kidney of normal and
STZ-induced diabetic rats
Examination of kidney apoptosis with TUNEL and PI staining
revealed an increase in TUNEL positive cells in the kidney sections
of diabetes control group as shown in Fig. 4. Kolaviron reduced
apoptotic cells in the kidney of diabetic rats.
Table 3
Effect of kolaviron on oxygen radical and lipid peroxidation in the kidney of diabetic
and non-diabetic rats.
MDA  (mol/g tissue) ORAC (mol  TE/g tissue)
C 2.09 ± 0.11 4.21 ± 0.86
C  + KV 2.06 ± 0.11 7.05 ± 0.78a
D 2.26 ± 0.12a 3.62 ± 0.76a
D + KV 1.96 ± 0.14b 7.13 ± 0.81b
Data are presented as mean ± S.D. C, non-diabetic control rats; C + KV, kolaviron-
treated control rats; D, untreated diabetic rats; D + KV, kolaviron-treated diabetic
rats; ORAC, oxygen radical absorbance capacity; TE, trolox equivalent; MDA, malon-
dialdehyde.
a Values differ signiﬁcantly from control (p < 0.05).
b Values differ signiﬁcantly from diabetic control (p < 0.05).
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Fig. 3. Effect of kolaviron on renal inﬂammation in diabetic and non-diabetic rats. Data are presented as mean ± S.D. (a) Values differ signiﬁcantly from non-diabetic control
(p  < 0.05). (b) Values differ signiﬁcantly from diabetic control (p < 0.05). C, non-diabetic control rats; C + KV, control treated with kolaviron; D, untreated diabetic rats; D + KV,
diabetic  rats treated with kolaviron.
Fig. 4. (a and b) Effect of kolaviron on diabetic induced apoptosis. Representative photomicrographs showing TUNEL-positive cells at 40× magniﬁcation in experimental
groups.  The cells emitting a green signal are TUNEL-positive apoptotic cells. TUNEL; terminal deoxynucleotidyltransferase mediated dUTP-biotin nick end labeling, PI;
propidium iodide. C, non-diabetic control rats; C + KV, control treated with kolaviron; D, untreated diabetic rats; D + KV, diabetic rats treated with kolaviron. Data are
presented as mean ± S.D. (a) Values differ signiﬁcantly from non-diabetic control (p < 0.05). (b) Values differ signiﬁcantly from diabetic control (p < 0.05). (For interpretation
of  the references to color in this ﬁgure legend, the reader is referred to the web  version of this article.)
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ontrol; (b) kolaviron-treated control rats; (c) diabetic rats and (d) kolaviron-treate
ffects of kolaviron on renal structure of rats
No pathological change was observed in kidney sections of rats
reated with kolaviron and was comparable to those of control rats
howing normal kidney architecture (Fig. 5a and b). STZ caused
egeneration of the glomerulus (Fig. 5c) with increased intersti-
ial matrix. Renal sections of diabetic rats treated with kolaviron
howed preserved renal glomerulus (Fig. 5d).
iscussion
Oxidative stress results from an imbalance between oxidants
nd antioxidants in favor of oxidants thus leading to cell damage.
ccumulation of reactive oxygen species (ROS) which causes oxida-
ive stress in tissues such as the kidney results in damage or toxicity
nd oxidative stress has been singled as a major cause of diabetic
omplications including diabetic nephropathy (Rolo and Palmeira
006). Cells maintain a variety of defenses in response to oxida-
ive stress through the induction of antioxidant enzymes. Among
hese are endogenous enzymatic antioxidants including superox-
de dismutase (SOD), catalase (CAT) and glutathione peroxidase
GPX). In the present study, GPX activity was increased in the dia-
etic kidney whereas catalase activity was decreased. However, in
olaviron-treated diabetic rats, CAT and GPX activities normalized.
PX uses the cellular non-enzymatic antioxidant glutathione (GSH)
s an electron donor to scavenge ROS generating products that can
asily be excreted out of the body (Sahoo et al. 2008). Therefore a
arked decline in renal GSH concentrations in diabetic rats may
eﬂect an impaired antioxidant defense and thus increased suscep-
ibility to oxidative stress. Kolaviron administered to diabetic and
on-diabetic control rats increased kidney GSH concentration. The
ormalization of GSH in kolaviron-treated diabetic rats therefore
uggests a protective effect of kolaviron against ROS overproduc-
ion in the diabetic rat kidney.
ROS degrade membrane polyunsaturated fatty acids through
equential peroxidation processes. The major products of lipid per-
xidation are 4-hydroxylnonenal (4-HNE) and malondialdehydeowing the renal structures of rats at 40× magniﬁcation in experimental groups. (a)
etic rats. Hematoxylin–eosin: 20×.
(MDA) (Demir et al. 2011). MDA  is a highly unstable aldehyde that
induces oxidative stress by forming covalent protein adducts col-
lectively referred to as advanced lipoxidation end-products (ALE)
(Farmer and Davoine 2007). The production of MDA  serves as a
bio-marker to measure tissue oxidative stress levels. Extensive
membrane lipid peroxidation impairs membrane ﬂuidity and inac-
tivates some membrane bound enzymes leading to cell death (Goel
et al. 2005). From our investigation, kolaviron may  prevent these
deleterious effects by inhibiting the lipid peroxidation process thus
reducing the formation of MDA. Previous studies identiﬁed some
active compounds in kolaviron which include Garcinia biﬂavonoids
(GB) 1, GB 2, kolaﬂavone and kolaﬂavanone (Iwu 1985). Recently,
we also identiﬁed a new compound in kolaviron which may be
another biﬂavonoid-binaringenin (Ayepola et al. 2013). The anti-
oxidative actions of kolaviron may  therefore be attributed to the
complex mixture of the ﬁve Garcinia seeds ﬂavonoids (Garcinia
biﬂavonoid (GB) 1, GB2, kolaﬂavone kolaﬂavanone and binarin-
genin) as shown in Fig. 2.
Kolaviron-treated diabetic rats have reduced IL-1 concentra-
tions with no effect on TNF- concentrations. IL-1 and TNF- are
pro-inﬂammatory cytokines produced by a wide range of cell types
and can exert their actions in a systemic, paracrine or autocrine
manner. IL-1 and TNF- regulate immunological and inﬂamma-
tory responses and have been implicated in diabetic kidney disease
through diverse biological activities including activation of growth
and transcription factors, impairment of insulin secretion and
induction of apoptosis and necrosis (Navarro-González et al. 2011;
Banerjee and Saxena 2012). IL-10, however, is an anti-inﬂammatory
cytokine which stimulates humoral immune responses and its ele-
vation in the serum of patients with diabetic nephropathy suggests
it plays a role in the pathogenesis of the disease (Wong et al. 2007;
Wu et al. 2011). We  did not ﬁnd differences in IL-10 concentra-
tions. The anti-inﬂammatory action of kolaviron in the diabetic
kidney may  therefore be related to the suppression of renal IL-1
production, independent of TNF-.
Apoptosis is a process of physiological cell death that maintains
tissue homeostasis; however, excessive or dysregulated apoptosis
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ay  lead to various pathological processes including diabetes
Kim et al. 2011). Hyperglycemic-induced oxidative stress has
een shown to result in pancreatic beta cell dysfunction and
poptosis (Donath et al. 1999). In vitro and in vivo diabetic kidney
tudies revealed that hyperglycemic-induced oxidative stress
lso triggers tubular and glomerular cells to undergo apoptosis
Brownlee 2001; Ha et al. 2008). In renal tubular epithelial cells,
levated glucose concentrations induce ROS-dependent apoptosis
y an increased Bax protein expression causing mitochondrial
ermeability and subsequently releasing cytochrome C (Kang
t al. 2003; Wagener et al. 2009). Apoptosis is also associated with
nﬂammation in diabetic nephropathy (Kim et al. 2011). Our study
emonstrated that renal apoptosis was induced in diabetic rats
ompared to the non-diabetic control rats while treatment of dia-
etic rats with kolaviron protected against the renal apoptosis. The
bility of kolaviron to inhibit oxidative damage by boosting renal
ntioxidant status is a possible mechanism of its anti-apoptotic
ctivity. IL-1 has been shown to induce Fas-triggered apoptosis
hrough the activation of the nuclear transcription factor NF-B.
he inhibitory action of kolaviron on IL-1 in the present study
otentially contributes to the anti-apoptotic effect of kolaviron.
The increased relative kidney weights of diabetic rats may
e due to fatty inﬁltration, enlargement of tubular cells lining
nd lymphocyte inﬁltration in hyperglycemic rats. Elevated con-
entrations of uric acid and blood urea nitrogen are related to
enal dysfunction in diabetes due to metabolic disturbances. More-
ver, metabolic disturbances and muscle wasting in diabetes can
lso result in an increased release of purine, a major source of
ric acid. Although uric acid is considered an antioxidant, its
xcessive generation could result from increased free radical pro-
uction due to activation of xanthine oxidase (Madianov et al.
000). Kolaviron treatment lowered blood urea nitrogen (BUN) and
erum uric acid levels in diabetic rats compared to untreated dia-
etic rats suggesting an ameliorative effect on kidney function.
e also observed reduced serum albumin concentrations in the
iabetic rats compared to non-diabetic rats which may  be due
o glomerular basement membrane damage and increased uri-
ary excretion of albumin which was normalized by kolaviron
reatment.
onclusion
The results of our study suggest that hyperglycemia caused renal
ysfunction and cell death via oxidative stress and inﬂammation.
e demonstrated the beneﬁcial effects of kolaviron on renal dys-
unction in diabetic rats via modulation of hyperglycemic-induced
nﬂammation, oxidative damage and apoptosis. Kolaviron should
e further explored as a potential candidate in the treatment of
iabetic nephropathy.
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